CFO4Life Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $415K | Buy |
|
|||||
|
2025
Q1 | $416K | Sell |
|
|||||
|
2024
Q4 | $394K | Buy |
|
|||||
|
2024
Q3 | $348K | Sell |
|
|||||
|
2024
Q2 | $405K | Buy |
|
|||||
|
2024
Q1 | $426K | Sell |
|
|||||
|
2023
Q4 | $755K | Sell |
|
|||||
|
2023
Q3 | $993K | Sell |
|
|||||
|
2023
Q2 | $1.13M | Buy |
|
|||||
|
2023
Q1 | $929K | Sell |
|
|||||
|
2022
Q4 | $968K | Sell |
|
|||||
|
2022
Q3 | $894K | Sell |
|
|||||
|
2022
Q2 | $901K | Buy |
|
|||||
|
2022
Q1 | $861K | Sell |
|
|||||
|
2021
Q4 | $1.07M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $272K | Sell |
|
|||||
|
2020
Q1 | $350K | Sell |
|
|||||
|
2019
Q4 | $404K | Buy |
|
|||||
|
2019
Q3 | $385K | Buy |
|
|||||
|
2019
Q2 | $408K | Buy |
|
|||||
|
2019
Q1 | $331K | Sell |
|
|||||
|
2018
Q4 | $372K | Buy |
|
|||||
|
2018
Q3 | $457K | Sell |
|
|||||
|
2018
Q2 | $424K | Sell |
|
|||||
|
2018
Q1 | $572K | Buy |
|
|||||
|
2017
Q4 | $541K | Sell |
|
|||||
|
2017
Q3 | $818K | Sell |
|
|||||
|
2017
Q2 | $738K | Buy |
|
|||||
|
2017
Q1 | $687K | Buy |
|